The choice of treatment in polycythaemia vera.
The current results of prospective protocols initiated by the Polycythaemia Vera Study Group are presented. These results help to define the best choice of treatment in accordance with the risk factors.
D001815:Bloodletting; D002699:Chlorambucil / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011897:Random Allocation
D010761:Phosphorus Radioisotopes; D002699:Chlorambucil; D006918:Hydroxyurea